← Leaderboards
Giovanna Rappocciolo
University Of Pittsburgh At Pittsburgh
$1,293,883
Attributed
$2,587,766
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $578.7K · FY2015–19$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,587,766 · 1
By mechanism
R01$2,587,766 · 1
Top collaborators
- Charles R Rinaldo5 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Charles R Rinaldo$100,535,685
- John W Mellors$70,850,753
- Stephen A Murray$43,730,323
- James T. Becker$26,719,242
- Adrian E Morelli$11,040,013
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroInfectionGeneticHiv InfectionsAutologousImmunologicsAntigen-Presenting CellsBloodArchivesGrantCell MembraneCholesterolCholesterol HomeostasisAntiretroviral TherapyApplications GrantsCytotoxic T-LymphocytesDendritic CellsDisease ProgressionB-LymphocytesEpigenetic ProcessExhibitsCd4 Positive T LymphocytesGenesLead
Grant awards (5)
Cholesterol-dependent control of HIV progression by antigen presenting cells$466,486
R01 · FY2019 · AI · contact PI
Cholesterol-dependent control of HIV progression by antigen presenting cells$507,143
R01 · FY2018 · AI · contact PI
Cholesterol-dependent control of HIV progression by antigen presenting cells$487,208
R01 · FY2017 · AI · contact PI
Cholesterol-dependent control of HIV progression by antigen presenting cells$578,731
R01 · FY2016 · AI
Cholesterol-dependent control of HIV progression by antigen presenting cells$548,198
R01 · FY2015 · AI